Source: Applied Clinical Trials

AliveCor: Beyond the Checkbox: How Rethinking Your Cardiac Monitoring Approach Can Dramatically Improve Trial Outcomes

AliveCor knows that cardiac safety is critical, with concerns often driving drug withdrawals from trials and the market. Our solutions go beyond compliance to boost regulatory trust, data integrity, and trial success. As the only company offering integrated 6L and 12L ECGs, we provide comprehensive monitoring-onsite and remotely-to meet complex cardiac requirements. Our innovative tools empower sponsors and CROs to control trial data, enabling faster, smarter decisions throughout the research lifecycle.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Priya Abani's photo - CEO of AliveCor

CEO

Priya Abani

CEO Approval Rating

48/100

Read more